In a latest update, the Intellectual Property Appellate Board (IPAB) comprising Z. S. Negi (Judicial Member) and P.C. Chakraborty (special Technical Member) convened in Chennai yesterday to issue directions. As per directions, the hearings of the appeals will commence on 17 November 2008. The hearings are expected to continue on a day-to-day basis and spill over into the next week. The hearings are to decide appeal filed by Novartis AG challenging the Indian Patent Controller’s decision to reject its patent application for the beta-crystalline form of Imatinib Mesylate (Gleevec).
On a lighter note, we have restarted Drug Patent Expiry after receiving innumerous requests from our readers.